Package 63323-616-03

{"route": ["INTRAVENOUS"], "spl_id": "262974e7-d551-4123-adfa-2ee1c4fa6195", "openfda": {"upc": ["0363323616021", "0363323616014"], "unii": ["976728SY6Z"], "rxcui": ["1663224", "1663244"], "spl_set_id": ["d8d04647-8e25-4127-8ecf-360ce1991c2f"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (63323-616-03)  / 3 mL in 1 VIAL, SINGLE-DOSE (63323-616-01)", "package_ndc": "63323-616-03", "marketing_start_date": "20030128"}, {"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 TRAY (63323-616-09)  / 9 mL in 1 VIAL, SINGLE-DOSE (63323-616-02)", "package_ndc": "63323-616-09", "marketing_start_date": "20030128"}], "brand_name": "Amiodarone Hydrochloride", "product_id": "63323-616_262974e7-d551-4123-adfa-2ee1c4fa6195", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "63323-616", "generic_name": "AMIODARONE HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amiodarone Hydrochloride", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA075761", "marketing_category": "ANDA", "marketing_start_date": "20030128", "listing_expiration_date": "20261231"}